Korsana Biosciences, Inc. (NasdaqCM: KRSA)
Health Care · Biotechnology · US
$32.68
+3.25% today · +235.9% 1Y
Korsana Biosciences, Inc. (NasdaqCM: KRSA) operates in the Biotechnology industry within the Health Care sector. The company is valued at $1.49B and employs 19 people.
Over the last twelve months the share price has gained 235.9%, trading between 7.19 and 59.36.
Tweenvest scores Korsana Biosciences, Inc. across four factors: quality 74/100. Its strongest factor is quality.
KRSA price history
Key figures
- Market cap
- $1.49B
- Revenue (TTM)
- —
- P/E
- —
- EPS
- -12.20
- Dividend yield
- —
- Beta (5Y)
- 1.84
- 52-week high
- $59.36
- 52-week low
- $7.19
- Avg volume (3M)
- —
- Shares outstanding
- 45.54M
- Employees
- 19
- Next earnings
- —
About Korsana Biosciences, Inc.
Korsana Biosciences, Inc. is a clinical-stage biotechnology company developing therapies for neurodegenerative diseases. Its lead program, KRSA-028, is an investigational shuttled antibody targeting amyloid beta for the treatment of Alzheimer's disease. The company became publicly traded in September 2026 through a merger with Cyclerion Therapeutics, Inc.
- ISIN
- US23255M3034
- Founded
- 2024
- Listed since
- Sep 9, 2026
- Exchange
- Nasdaq Capital Market
- Currency
- USD
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Zhuhai Trinomab Pharmaceutical Co., Ltd.SHSE: 688806 | $1.52B | CN¥21.97 | -5.02% |
| Voronoi, Inc.KOSDAQ: A310210 | $1.51B | ₩111,000.00 | +1.19% |
| CanSino Biologics Inc.SEHK: 6185 | $1.50B | HK$23.34 | -1.85% |
| AlvotechNasdaqGM: ALVO | $1.50B | $4.19 | -10.28% |
| Ab&B Bio-Tech CO., LTD. JSSEHK: 2627 | $1.47B | HK$29.32 | -1.01% |
| Biotest GmbH & Co. KGaAHMSE: BIO0 | $1.46B | €33.40 | -0.60% |
| uniQure N.V.NasdaqGS: QURE | $1.42B | $20.30 | -2.24% |
| Absci CorporationNasdaqGS: ABSI | $1.41B | $8.18 | +7.92% |